Damsky, William, Wang, Alice, Kim, Daniel J., Young, Bryan D., Singh, Katelyn, Murphy, Michael J., Daccache, Joseph, Clark, Abigale, Ayasun, Ruveyda, Ryu, Changwan, McGeary, Meaghan K., Odell, Ian D., Fazzone-Chettiar, Ramesh, Pucar, Darko, Homer, Robert, Gulati, Mridu, Miller, Edward J., Bosenberg, Marcus, Flavell, Richard A., King, Brett (2022) Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nature Communications, 13 (1) doi:10.1038/s41467-022-30615-x
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis | ||
| Journal | Nature Communications | ||
| Authors | Damsky, William | Author | |
| Wang, Alice | Author | ||
| Kim, Daniel J. | Author | ||
| Young, Bryan D. | Author | ||
| Singh, Katelyn | Author | ||
| Murphy, Michael J. | Author | ||
| Daccache, Joseph | Author | ||
| Clark, Abigale | Author | ||
| Ayasun, Ruveyda | Author | ||
| Ryu, Changwan | Author | ||
| McGeary, Meaghan K. | Author | ||
| Odell, Ian D. | Author | ||
| Fazzone-Chettiar, Ramesh | Author | ||
| Pucar, Darko | Author | ||
| Homer, Robert | Author | ||
| Gulati, Mridu | Author | ||
| Miller, Edward J. | Author | ||
| Bosenberg, Marcus | Author | ||
| Flavell, Richard A. | Author | ||
| King, Brett | Author | ||
| Year | 2022 (June 6) | Volume | 13 |
| Issue | 1 | ||
| Publisher | Springer Science and Business Media LLC | ||
| DOI | doi:10.1038/s41467-022-30615-xSearch in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 15150811 | Long-form Identifier | mindat:1:5:15150811:4 |
| GUID | 0 | ||
| Full Reference | Damsky, William, Wang, Alice, Kim, Daniel J., Young, Bryan D., Singh, Katelyn, Murphy, Michael J., Daccache, Joseph, Clark, Abigale, Ayasun, Ruveyda, Ryu, Changwan, McGeary, Meaghan K., Odell, Ian D., Fazzone-Chettiar, Ramesh, Pucar, Darko, Homer, Robert, Gulati, Mridu, Miller, Edward J., Bosenberg, Marcus, Flavell, Richard A., King, Brett (2022) Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nature Communications, 13 (1) doi:10.1038/s41467-022-30615-x | ||
| Plain Text | Damsky, William, Wang, Alice, Kim, Daniel J., Young, Bryan D., Singh, Katelyn, Murphy, Michael J., Daccache, Joseph, Clark, Abigale, Ayasun, Ruveyda, Ryu, Changwan, McGeary, Meaghan K., Odell, Ian D., Fazzone-Chettiar, Ramesh, Pucar, Darko, Homer, Robert, Gulati, Mridu, Miller, Edward J., Bosenberg, Marcus, Flavell, Richard A., King, Brett (2022) Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nature Communications, 13 (1) doi:10.1038/s41467-022-30615-x | ||
| In | (2022, December) Nature Communications Vol. 13 (1) Springer Science and Business Media LLC | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
